Skip to content
dextrothyroxine

Structure via PubChem · Public domain (PubChem)

EntityQ5268499· pop 11· linked from 145 articles

dextrothyroxine

Sign in to save

Also known as Choloxin®, D-T4, D-thyroxine, O-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo-D-tyrosine, DT4, O-(4-Hydroxy-3,5-diiodophenyl)-3,5-diiodo-D-tyrosine

Dextrothyroxine (trade name Choloxin) is a dextrorotary isomer of thyroxine. It saw research as a cholesterol-lowering drug but was pulled due to cardiac side-effects. It increases hepatic lipase which in turn improves utilization of triglycerides and decreases levels of lipoprotein(a) in blood serum.

Chemical data

Formula
C15H11I4NO4
Molecular weight
776.87 g/mol
IUPAC name
(2R)-2-azaniumyl-3-[4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]propanoate

via PubChem

Drug data · ChEMBL

Max clinical phase
Approved
Molecule type
Small molecule
First approval
1967
Admin. routes
oral
Indications
cardiovascular disease, Down syndrome

via ChEMBL · EBI

Research

309 papers

via PubMed

Wikidata facts

Mass
776.6867
Show 4 more facts
chemical formula
C₁₅H₁₁I₄NO₄
canonical SMILES
C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N
isomeric SMILES
C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)C[C@H](C(=O)O)N
defined daily dose
4
Sources (3)

via Wikidata · CC0

~1 min read

Article

1 sections
Contents
  • References

Dextrothyroxine (trade name Choloxin) is a dextrorotary isomer of thyroxine. It saw research as a cholesterol-lowering drug but was pulled due to cardiac side-effects. It increases hepatic lipase which in turn improves utilization of triglycerides and decreases levels of lipoprotein(a) in blood serum.

== References ==

Connections

Categories